Walleye Trading LLC increased its holdings in shares of Option Care Health, Inc. (NASDAQ:OPCH - Free Report) by 159.7% in the fourth quarter, according to the company in its most recent filing with the Securities and Exchange Commission (SEC). The firm owned 25,969 shares of the company's stock after purchasing an additional 15,969 shares during the period. Walleye Trading LLC's holdings in Option Care Health were worth $602,000 as of its most recent SEC filing.
A number of other institutional investors have also modified their holdings of OPCH. Vanguard Group Inc. grew its position in Option Care Health by 0.4% in the 4th quarter. Vanguard Group Inc. now owns 19,315,421 shares of the company's stock valued at $448,118,000 after buying an additional 75,313 shares during the last quarter. Wellington Management Group LLP boosted its holdings in shares of Option Care Health by 84.6% in the fourth quarter. Wellington Management Group LLP now owns 18,325,123 shares of the company's stock valued at $425,143,000 after acquiring an additional 8,400,208 shares in the last quarter. Norges Bank acquired a new position in shares of Option Care Health during the fourth quarter worth about $60,219,000. Charles Schwab Investment Management Inc. raised its holdings in Option Care Health by 6.2% during the fourth quarter. Charles Schwab Investment Management Inc. now owns 2,510,131 shares of the company's stock worth $58,235,000 after purchasing an additional 147,054 shares in the last quarter. Finally, Magnetar Financial LLC lifted its position in Option Care Health by 23.1% in the fourth quarter. Magnetar Financial LLC now owns 2,350,598 shares of the company's stock valued at $54,534,000 after purchasing an additional 441,265 shares during the period. Institutional investors and hedge funds own 98.05% of the company's stock.
Wall Street Analyst Weigh In
Several equities analysts have issued reports on the company. Bank of America upgraded Option Care Health from a "neutral" rating to a "buy" rating and boosted their target price for the stock from $26.00 to $33.00 in a research report on Monday, January 13th. Barrington Research reaffirmed an "outperform" rating and set a $38.00 price objective on shares of Option Care Health in a report on Monday. Jefferies Financial Group raised Option Care Health from a "hold" rating to a "buy" rating and raised their target price for the company from $26.00 to $35.00 in a report on Thursday, January 23rd. JMP Securities reaffirmed a "market outperform" rating and set a $36.00 price target on shares of Option Care Health in a research note on Tuesday. Finally, JPMorgan Chase & Co. upped their target price on shares of Option Care Health from $40.00 to $41.00 and gave the stock an "overweight" rating in a research report on Thursday, March 6th. Two equities research analysts have rated the stock with a hold rating and six have issued a buy rating to the stock. Based on data from MarketBeat, the stock currently has an average rating of "Moderate Buy" and a consensus target price of $33.75.
Check Out Our Latest Stock Report on OPCH
Option Care Health Price Performance
Shares of NASDAQ OPCH traded up $0.17 during trading on Friday, reaching $32.35. The company had a trading volume of 363,206 shares, compared to its average volume of 1,773,876. The company has a current ratio of 1.73, a quick ratio of 1.32 and a debt-to-equity ratio of 0.77. The stock has a market capitalization of $5.31 billion, a PE ratio of 27.17, a price-to-earnings-growth ratio of 2.30 and a beta of 1.07. Option Care Health, Inc. has a twelve month low of $21.39 and a twelve month high of $35.53. The stock has a 50-day moving average price of $33.34 and a two-hundred day moving average price of $28.73.
Insiders Place Their Bets
In other Option Care Health news, insider Michael Bavaro sold 30,996 shares of Option Care Health stock in a transaction that occurred on Friday, February 28th. The shares were sold at an average price of $33.26, for a total value of $1,030,926.96. Following the completion of the sale, the insider now directly owns 44,974 shares of the company's stock, valued at approximately $1,495,835.24. The trade was a 40.80 % decrease in their position. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.64% of the stock is owned by corporate insiders.
About Option Care Health
(
Free Report)
Option Care Health, Inc offers home and alternate site infusion services in the United States. The company provides anti-infective therapies; home infusion services to treat heart failures; home parenteral nutrition and enteral nutrition support services for numerous acute and chronic conditions, such as stroke, cancer, and gastrointestinal diseases; immunoglobulin infusion therapies for the treatment of immune deficiencies; and treatments for chronic inflammatory disorders, including crohn's disease, plaque psoriasis, psoriatic arthritis, rheumatoid arthritis, ulcerative colitis, and other chronic inflammatory disorders.
Featured Articles
Before you consider Option Care Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Option Care Health wasn't on the list.
While Option Care Health currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
